Information
-
Trademark
-
87449741
-
International Classifications
-
Filing Date
May 15, 2017
7 years ago
-
Transaction Date
January 07, 2020
5 years ago
-
Status Date
January 07, 2020
5 years ago
-
Published for Opposition Date
July 30, 2019
5 years ago
-
Location Date
September 24, 2019
5 years ago
-
Status Code
605
-
Current Location
INTENT TO USE SECTION
Employee Name
ENGEL, MICHAEL L
-
Attorney Docket Number
255556000016
Attorney Name
Karl M. Zielaznicki, Esq.
Law Office Assigned Location Code
L70
-
Owners
Mark Drawing Code
3000
Mark Identification
ALUNBRIG 1POINT
Case File Statements
- CC0000: The color(s) aqua, gray, yellow, white, and red-orange is/are claimed as a feature of the mark.
- DM0000: The mark consists of a succession of seven various sized arcs, three in yellow, two in aqua, and two in red-orange, appearing above the word "ALUNBRIG" in stylized aqua lettering and to the right, a thin light grey vertical line, followed by the number "1" in white, appearing in the overlapping area of two triangles, one in grey and one in shades of aqua, being partially obstructed by the letter "P" in the word "POINT", in aqua stylized lettering, to the right of the triangles. All white areas other than the number "1" are background and/or transparent areas and are not part of the mark.
- GS0351: Business administration of patient reimbursement programs; business administration of medication reimbursement programs and services
- GS0361: Financial administration of patient reimbursement program; financial administration of medication reimbursement programs and services; providing insurance and insurance reimbursement information
- GS0421: Providing medical and scientific research information in the field of haematological malignancies, cancer, auto-immune and inflammatory diseases and disorders
- GS0441: Providing medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; Providing information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer, auto-immune diseases and inflammatory diseases and disorders
- PM0001: ALUNBRIG ONE POINT
Case File Event Statements
-
1/7/2020 - 5 years ago
48 - ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Type: MAB5
-
1/7/2020 - 5 years ago
47 - ABANDONMENT - AFTER PUBLICATION
Type: ABN5
-
1/6/2020 - 5 years ago
46 - TEAS EXPRESS ABANDONMENT RECEIVED
Type: EXAR
-
9/23/2019 - 5 years ago
45 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
9/23/2019 - 5 years ago
44 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
9/24/2019 - 5 years ago
43 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
8/29/2019 - 5 years ago
42 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
7/30/2019 - 5 years ago
41 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
7/30/2019 - 5 years ago
40 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
7/10/2019 - 5 years ago
39 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
6/26/2019 - 5 years ago
38 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
6/21/2019 - 5 years ago
37 - ASSIGNED TO LIE
Type: ALIE
-
6/10/2019 - 5 years ago
36 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
6/7/2019 - 5 years ago
35 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
6/7/2019 - 5 years ago
34 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
6/7/2019 - 5 years ago
33 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
3/5/2019 - 5 years ago
32 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
3/5/2019 - 5 years ago
31 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
3/5/2019 - 5 years ago
30 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/5/2019 - 5 years ago
29 - PREVIOUS ALLOWANCE COUNT WITHDRAWN
Type: ZZZX
-
1/22/2019 - 6 years ago
28 - WITHDRAWN FROM PUB - OG REVIEW QUERY
Type: PBCR
-
12/20/2018 - 6 years ago
27 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
6/22/2018 - 6 years ago
26 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
6/20/2018 - 6 years ago
25 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/20/2018 - 6 years ago
24 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
6/20/2018 - 6 years ago
23 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
6/1/2018 - 6 years ago
22 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
5/31/2018 - 6 years ago
21 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
5/31/2018 - 6 years ago
20 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
5/30/2018 - 6 years ago
19 - NOTIFICATION OF PRIORITY ACTION E-MAILED
Type: GPRN
-
5/30/2018 - 6 years ago
18 - PRIORITY ACTION E-MAILED
Type: GPRA
-
5/30/2018 - 6 years ago
17 - PRIORITY ACTION WRITTEN
Type: CPRA
-
5/19/2018 - 6 years ago
16 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
5/18/2018 - 6 years ago
15 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
5/18/2018 - 6 years ago
14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
11/18/2017 - 7 years ago
13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
11/18/2017 - 7 years ago
12 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
11/18/2017 - 7 years ago
11 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
11/15/2017 - 7 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
11/14/2017 - 7 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
11/14/2017 - 7 years ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
8/17/2017 - 7 years ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
8/17/2017 - 7 years ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
8/17/2017 - 7 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
8/9/2017 - 7 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
5/20/2017 - 7 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSM
-
5/19/2017 - 7 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
5/18/2017 - 7 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP